EUVIMEDOpdag EUVIMED
BeobachtungsstudieOpen access · CC BY-NC 4.0

Unlocking Relief: Investigating the Impact of a Fixed Combination of Acetyl‐L‐Carnitine and Palmitoylethanolamide on Traumatic Acute Low Back Pain

Mattia Cominacini iD, Maria Teresa Valenti iD, Michele Braggio, Alberto Caramori, Ermes Vedovi, Luca Dalle Carbonare

European Journal of Neurology · 2025-08 · 32 (8)

DOI: 10.1111/ene.70334 ↗

At a glance

Beobachtungsstudie in European Journal of Neurology, published online on 2025-08-25. Written by Mattia Cominacini and 5 co-authors. Institution: Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy. Major MEDLINE topics: Acetylcarnitine, Palmitic Acids, Ethanolamines, Low Back Pain. Cited 5 times so far (Crossref); 49 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Chiesi Italia S.p.A.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Peripheral neuropathies encompass a diverse group of disorders involving peripheral nerve damage, often leading to pain, sensory disturbances, and motor impairments. The etiology is multifactorial, with trauma as a key contributor. The treatment of peripheral neuropathies includes medications targeting the nociceptive component, whereas the neuropathic component is managed with agents such as gabapentinoids or antidepressants, though their prolonged use is limited by significant side effects. Some neuroprotective compounds, such as acetyl‐L‐carnitine (ALC), palmitoylethanolamide (PEA), and alpha‐lipoic acid (ALA), have emerged as potential alternatives due to their anti‐inflammatory and analgesic properties.

Methods

This monocentric, observational, single‐arm longitudinal study evaluated the efficacy of a fixed combination containing ALC, PEA, and ALA (as an adjuvant to the previous two) and Boswellia serrata , Vitamin E, and Vitamin B6 in patients with acute low back trauma. Over 8 weeks, 48 participants received the supplement alongside conventional therapy. The primary end point was improvement in neuropathic pain assessed via the Neuropathic Pain Scale (NPS) and Visual Analogue Scale (VAS). Secondary endpoints included quality of life (SF‐36) changes, reduced NSAID consumption, and adverse events.

Results

The study showed significant reductions in NPS and VAS scores and improvements in physical health‐related SF‐36 domains, with reduced NSAID consumption. Participants with more severe baseline symptoms demonstrated the greatest benefits. No significant changes were observed in emotional parameters. Adverse events were mild and in a very limited number of patients.

Conclusions

Results suggest the combination's potential to improve pain and reduce reliance on conventional therapies; however, further controlled randomized trials are needed to validate these findings.

Subjects

MeSH terms (MEDLINE)

AcetylcarnitinePalmitic AcidsEthanolaminesLow Back PainAnalgesicsHumansMaleFemaleMiddle AgedAdultAmidesLongitudinal StudiesDrug CombinationsAgedTreatment OutcomePain MeasurementNeuralgiaVitamin EVitamin B 6

Author keywords

Boswellia serrataacetyl‐L‐carnitinealpha‐lipoic acidneuroprotectivespalmitoylethanolamideperipheral neurophatiesvitamin Bvitamin E

Substances

palmidrolAcetylcarnitinePalmitic AcidsEthanolaminesAmidesDrug CombinationsAnalgesicsVitamin EVitamin B 6

Authors and institutions

  • Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy.
  • Department of Neurosciences, Biomedicines and Movement Medicine, University of Verona, Verona, Italy.
  • Functional Recovery and Rehabilitation Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.

ORCID profiles: Mattia Cominacini, Maria Teresa Valenti

Funding

  • Chiesi Italia S.p.A

Cite

APA

Cominacini, M., Valenti, M. T., Braggio, M., Caramori, A., Vedovi, E., & Dalle Carbonare, L. (2025). Unlocking Relief: Investigating the Impact of a Fixed Combination of Acetyl‐L‐Carnitine and Palmitoylethanolamide on Traumatic Acute Low Back Pain. European Journal of Neurology, 32(8). https://doi.org/10.1111/ene.70334

Vancouver

Cominacini M, Valenti MT, Braggio M, Caramori A, Vedovi E, Dalle Carbonare L. Unlocking Relief: Investigating the Impact of a Fixed Combination of Acetyl‐L‐Carnitine and Palmitoylethanolamide on Traumatic Acute Low Back Pain. European Journal of Neurology. 2025;32(8). doi:10.1111/ene.70334

BibTeX
@article{Cominacini2025,
  author = {Cominacini, Mattia and Valenti, Maria Teresa and Braggio, Michele and Caramori, Alberto and Vedovi, Ermes and Dalle Carbonare, Luca},
  title = {Unlocking Relief: Investigating the Impact of a Fixed Combination of Acetyl‐L‐Carnitine and Palmitoylethanolamide on Traumatic Acute Low Back Pain},
  journal = {European Journal of Neurology},
  year = {2025},
  volume = {32},
  number = {8},
  doi = {10.1111/ene.70334}
}
Start for free →